Company Filing History:
Years Active: 2023
Title: The Innovations of Patrick Strube
Introduction
Patrick Strube is an accomplished inventor based in Jena, Germany. He has made significant contributions to the field of medical research, particularly in the area of spinal fusion surgery. His innovative work focuses on predicting non-fusion outcomes, which can greatly impact patient care and treatment strategies.
Latest Patents
Strube holds a patent titled "CD8 T cell subsets as a biomarker for predicting non-fusion after spinal fusion surgery." This patent outlines a method for predicting the probability of developing a non-fusion by determining the frequency of specific subpopulations of CD8+ T cells in patient samples. The method includes the analysis of CD8+CD57+, CD8+CD28−, and CD8+CD57+CD28− T cell subsets. This innovative approach provides a system for predicting non-fusion probabilities, which can enhance surgical outcomes.
Career Highlights
Throughout his career, Patrick Strube has worked with prestigious institutions, including Charité-Universitätsmedizin Berlin. His research has contributed to advancements in understanding immune responses related to spinal surgery. Strube's work is recognized for its potential to improve patient prognoses and surgical techniques.
Collaborations
Strube has collaborated with notable colleagues such as Simon Reinke and Sven Geissler. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation in the medical field.
Conclusion
Patrick Strube's contributions to medical research, particularly through his patent on CD8 T cell subsets, demonstrate his commitment to improving patient care in spinal fusion surgery. His work exemplifies the importance of innovation in medicine and its potential to transform surgical practices.